Cite
HARVARD Citation
Ma, R. et al. (2018). AZ304, a novel dual BRAF inhibitor, exerts anti-tumour effects in colorectal cancer independently of BRAF genetic status. British journal of cancer. 118 (11), pp. 1453-1463. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ma, R. et al. (2018). AZ304, a novel dual BRAF inhibitor, exerts anti-tumour effects in colorectal cancer independently of BRAF genetic status. British journal of cancer. 118 (11), pp. 1453-1463. [Online].